Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label, Reclast®/Aclasta®, Re-treatment of Relapsed Patients With Paget's Disease of Bone Who Participated in the CZOL446K2304 and CZOL446K2305 Core Registration Studies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00740129
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:09.825996+00:00
Published At
2021-05-26T00:00:00+00:00
Record Updated At
2021-05-26
Results Posted At
2021-05-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Paget\u0027s Disease of the Bone"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-05-26"
protocolSection.identificationModule.nctId
"NCT00740129"
protocolSection.identificationModule.officialTitle
"An Open Label, Reclast\u00ae/Aclasta\u00ae, Re-treatment of Relapsed Patients With Paget\u0027s Disease of Bone Who Participated in the CZOL446K2304 and CZOL446K2305 Core Registration Studies"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-05-26"

Study condition terms

  • Paget's Disease of the Bone (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.